Reference: Leonidas H. Duntas et al Endocrine volume 66, pages 63–69 (2019) Dr.Guttler’s comments: 1. The population is aging with millions of people today living into their 90 s. 2.Hypothyroidism, is widespread and it is expected to...
More info
Dr.Guttler’s Patient Thyroid Blog Post: New Drug for Graves’ Thyroid Eye Disease TED Dr.Guttler’s comments: 1. An editorial on the new drug Teprotumumab for TED. 2. First Food and Drug Administration (FDA)-approved treatment for...
More info
Dr.Guttler’s Patient Thyroid Blog Post: Why Anti-Thyroid Drugs Are The Best Treatment Over Surgery or Radioiodine. Dr.Guttler’s comments: 1. This article reviews results in 4600 Graves’ patients. 2.Patients received ATD...
More info
Thyroid RFA for Benign Nodules: Relief of Symptoms is the goal not total Ablation with increased risk of complications. The recent use of thyroid RFA for benign nodules has as it’s goal to relief symptoms and improve the cosmetic...
More info
Baek JH et al Int.J. Hyperther Dec 2021 Dr.Guttler’s Comments: 1.The electrode has a micro hole in the tip to inject chilled normal saline at 1.5 ml/minute. 2. The results in 20 patients was comparable to results with the standard...
More info
Dr.Guttler’s comments: 1. Graves’ disease was triggered by the SARS-CoV-2 vaccination. Clinicians need to be vigilant of precipitation or exacerbation of autoimmune thyroid disorders in predisposed individuals after exposure to the...
More info
DR.Guttler’s Patient Thyroid Blog Post: More extensive total thyroidectomy than is needed in 50% of Cases with class V cytology. Dr.Guttler’s comments: 25%-50% of Bethesda V thyroid nodules may be benign, noninvasive follicular...
More infoDr.Guttler’s comments: Most thyroid cancers are low risk papillary thyroid cancers. Follicular and medullary are intermediate risk. The worst one is anaplastic and Putin would be dead by now. Only Putin would have a thyroid cancer surgeon...
More info